(Q33503482)

English

IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

G Fleischhack

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

C Hasan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

G Mann

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

U Bode

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

0 references

publication date

1 August 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

647-655

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9722289%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

Biochemical modulation of arabinosylcytosine for therapy of leukemias

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

The characteristics and outcome of patients with late relapse acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

Response to salvage therapy and survival after relapse in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

The effect of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 1-beta-D-arabinofuranosylcytosine on the cell cycle phase distribution, topoisomerase II level, mitoxantrone cytotoxicity, and DNA strand break production in K562 human leukemia cells.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

FLAG (fludarabine, cytosine arabinoside, G-CSF) for refractory and relapsed acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1998.00836.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33503482&oldid=1623072166"